D. Western Therapeutics Institute
4576
Needs Well
3992
Daiwa Cycle
5888
Osaka Yuka Industry
4124
Liberta
4935
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 9.88%40.86B | 1,267.92%37.18B | -80.23%2.72B | -41.66%13.75B | 6,252.56%23.57B | -96.84%371M | -6.18%11.73B | 6.23%12.51B | 0.31%11.77B | 123.90%11.74B |
Net profit before non-cash adjustment | -13.43%28.1B | 52.05%32.46B | 47.51%21.35B | 55.85%14.47B | -3.76%9.29B | 3.75%9.65B | 18.74%9.3B | 3.35%7.83B | 4.08%7.58B | 28.66%7.28B |
Total adjustment of non-cash items | -39.33%3.36B | 14.40%5.53B | 533.93%4.83B | -128.57%-1.11B | 1,721.96%3.9B | -77.89%214M | -28.24%968M | -22.78%1.35B | -29.33%1.75B | -3.25%2.47B |
-Depreciation and amortization | 5.67%4.28B | 5.35%4.05B | 17.28%3.85B | 15.04%3.28B | 56.27%2.85B | 16.32%1.83B | 1.88%1.57B | -12.25%1.54B | -13.72%1.76B | -20.11%2.03B |
-Reversal of impairment losses recognized in profit and loss | -97.52%16M | 592.47%644M | -95.09%93M | 398.16%1.89B | 1,125.81%380M | -86.40%31M | 1,325.00%228M | -48.39%16M | 24.00%31M | -85.88%25M |
-Share of associates | 182.47%80M | -120.55%-97M | -24.72%472M | -30.72%627M | 366.49%905M | 74.77%194M | --111M | ---- | ---- | ---- |
-Disposal profit | -524.81%-1.66B | -163.37%-266M | -118.91%-101M | -30.74%534M | 124.13%771M | 144.05%344M | -2,131.43%-781M | -294.44%-35M | -93.00%18M | 148.04%257M |
-Other non-cash items | -46.69%637M | 128.93%1.2B | 107.01%522M | -638.26%-7.45B | 53.72%-1.01B | -1,271.07%-2.18B | 7.56%-159M | -201.75%-172M | -136.54%-57M | -57.49%156M |
Changes in working capital | 1,260.62%9.4B | 96.55%-810M | -6,101.02%-23.46B | -96.23%391M | 209.39%10.38B | -747.92%-9.49B | -55.94%1.47B | 35.83%3.33B | 23.39%2.45B | 166.76%1.98B |
-Change in receivables | 1,467.81%18.78B | 83.11%-1.37B | -124.22%-8.13B | -144.19%-3.63B | 702.72%8.2B | -145.37%-1.36B | 30.21%3B | -2.29%2.3B | -40.60%2.36B | 170.43%3.97B |
-Change in inventory | -51.21%4.55B | 142.18%9.32B | -837.00%-22.09B | -60.86%3B | 457.02%7.66B | -849.12%-2.15B | 5.83%-226M | -108.97%-240M | 3,288.61%2.68B | 104.63%79M |
-Change in prepaid assets | 246.76%612M | -130.91%-417M | 486.53%1.35B | 75.61%-349M | -590.07%-1.43B | 316.30%292M | -194.41%-135M | 142.69%143M | -170.08%-335M | 222.88%478M |
-Change in payables | -6.55%-12.26B | -569.32%-11.5B | 63.95%2.45B | 122.42%1.5B | 1.17%-6.67B | -512.72%-6.75B | -218.01%-1.1B | 138.76%933M | 23.37%-2.41B | -204.77%-3.14B |
-Change in accrued expense | -147.79%-475M | 12.06%994M | 647.53%887M | -142.19%-162M | -30.43%384M | 63.31%552M | 651.11%338M | 104.55%45M | -82.95%22M | -59.69%129M |
-Provision for loans, leases and other losses | -91.00%227M | 743.14%2.52B | -81.75%299M | 4,327.03%1.64B | 121.89%37M | -533.33%-169M | -73.10%39M | 155.77%145M | -185.81%-260M | 1,783.33%303M |
-Changes in other current assets | 147.77%354M | -180.68%-741M | 33.50%-264M | -526.88%-397M | 148.69%93M | -117.05%-191M | -198.88%-88M | 250.85%89M | -103.97%-59M | 74,150.00%1.49B |
-Changes in other current liabilities | -706.87%-2.39B | -80.64%393M | 268.33%2.03B | -157.26%-1.21B | 663.04%2.11B | 176.24%276M | -285.11%-362M | -120.80%-94M | 134.27%452M | -190.34%-1.32B |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -20.08%-879M | -132.38%-732M | 2.17%-315M | -1.90%-322M | -67.20%-316M | -45.38%-189M | -1.56%-130M | 4.48%-128M | -13.56%-134M | 10.61%-118M |
Interest received (cash flow from operating activities) | 132.79%1.14B | 295.97%491M | -63.74%124M | -28.90%342M | 37.82%481M | 44.21%349M | 47.56%242M | -2.96%164M | -29.88%169M | 66.21%241M |
Tax refund paid | -84.18%-11.74B | -49.47%-6.37B | -29.38%-4.26B | -80.15%-3.3B | 11.98%-1.83B | -17.40%-2.08B | 1.23%-1.77B | 20.60%-1.79B | 16.00%-2.26B | -48.45%-2.69B |
Other operating cash inflow (outflow) | 0.00%2M | -98.90%2M | 138.32%182M | -194.62%-475M | 502M | 0 | 150.00%2M | 20.00%-4M | 89.13%-5M | 58.56%-46M |
Operating cash flow | -3.87%29.39B | 2,067.12%30.57B | -115.54%-1.55B | -55.37%10B | 1,548.35%22.41B | -115.35%-1.55B | -6.23%10.08B | 12.57%10.75B | 4.59%9.55B | 173.76%9.13B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | -47.28%-5.39B | -12.73%-3.66B | -30.49%-3.24B | 17.27%-2.49B | -3.05%-3.01B | -83.28%-2.92B | -87.62%-1.59B | 11.30%-848M | 3.04%-956M | 44.26%-986M |
Net intangibles purchase and sale | 28.05%-336M | 66.09%-467M | -30.03%-1.38B | -198.31%-1.06B | 15.48%-355M | -16.67%-420M | -230.28%-360M | 58.24%-109M | 11.22%-261M | -13.51%-294M |
Net business purchase and sale | --555M | --0 | ---- | 833.96%2.36B | -12.24%-321M | -156.75%-286M | 2,420.00%504M | 150.00%20M | 138.10%8M | 88.59%-21M |
Net investment product transactions | 4,266.67%1.88B | 92.94%-45M | 40.47%-637M | -291.41%-1.07B | 117.91%559M | -12.87%-3.12B | -508.57%-2.77B | 580.14%677M | 51.88%-141M | 62.10%-293M |
Advance cash and loans provided to other parties | 90.19%-42M | 72.70%-428M | -844.58%-1.57B | 69.87%-166M | -27,450.00%-551M | -100.00%-2M | 50.00%-1M | 33.33%-2M | 78.57%-3M | 65.85%-14M |
Repayment of advance payments to other parties and cash income from loans | ---- | ---- | ---- | ---- | -66.67%1M | 200.00%3M | -80.00%1M | 150.00%5M | -83.33%2M | 1,100.00%12M |
Net changes in other investments | 275.96%366M | -485.19%-208M | 292.86%54M | -233.33%-28M | 117.95%21M | -392.50%-117M | 4,100.00%40M | -101.14%-1M | -32.82%88M | 141.72%131M |
Investing cash flow | 38.23%-2.97B | 29.05%-4.81B | -176.07%-6.77B | 32.81%-2.45B | 46.78%-3.65B | -64.39%-6.86B | -1,517.44%-4.17B | 79.57%-258M | 13.79%-1.26B | 56.12%-1.47B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -1.18%-10.27B | -184.81%-10.15B | 1,449.27%11.97B | 82.55%-887M | -136.66%-5.08B | 1,799.51%13.87B | 70.42%-816M | -64.72%-2.76B | 48.75%-1.68B | -263.56%-3.27B |
Net common stock issuance | -200.00%-6M | 99.95%-2M | -368,000.00%-3.68B | ---1M | --0 | 50.00%-1M | 99.87%-2M | -150,000.00%-1.5B | 0.00%-1M | 0.00%-1M |
Cash dividends paid | -31.44%-6.03B | -79.93%-4.59B | -32.73%-2.55B | 6.52%-1.92B | -0.10%-2.06B | -15.39%-2.05B | -5.14%-1.78B | -33.31%-1.69B | -28.67%-1.27B | -16.53%-987M |
Cash dividends for minorities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 |
Net other fund-raising expenses | 17.72%-664M | 82.38%-807M | -13.36%-4.58B | -900.25%-4.04B | -213.18%-404M | 39.44%-129M | -29.09%-213M | -36.36%-165M | 30.86%-121M | -44.63%-175M |
Financing cash flow | -9.16%-16.97B | -1,446.23%-15.55B | 116.86%1.16B | 9.19%-6.85B | -164.57%-7.54B | 515.65%11.68B | 54.05%-2.81B | -99.48%-6.12B | 30.78%-3.07B | -532.71%-4.43B |
Net cash flow | ||||||||||
Beginning cash position | 28.20%50.31B | -11.49%39.24B | 3.84%44.33B | 32.46%42.69B | 11.61%32.23B | 10.98%28.88B | 18.93%26.02B | 24.53%21.88B | 31.49%17.57B | 12.49%13.36B |
Current changes in cash | -7.55%9.44B | 242.45%10.22B | -1,131.80%-7.17B | -93.80%695M | 242.11%11.21B | 5.95%3.28B | -29.22%3.09B | -16.22%4.37B | 61.44%5.22B | 217.08%3.23B |
Effect of exchange rate changes | 213.03%2.67B | -59.02%852M | 120.00%2.08B | 226.34%945M | -1,097.33%-748M | 132.05%75M | -3.08%-234M | 74.92%-227M | -192.63%-905M | 111.02%977M |
Cash adjustments other than cash changes | ---1M | ---- | ---1M | ---- | ---1M | ---- | 0.00%-1M | 0.00%-1M | ---1M | ---- |
End cash Position | 24.07%62.42B | 28.20%50.31B | -11.49%39.24B | 3.84%44.33B | 32.46%42.69B | 11.61%32.23B | 10.98%28.88B | 18.93%26.02B | 24.53%21.88B | 31.49%17.57B |
Free cash flow | -10.52%23.63B | 525.50%26.41B | -196.59%-6.21B | -65.77%6.43B | 475.95%18.78B | -162.12%-4.99B | -16.87%8.04B | 22.53%9.67B | 5.61%7.89B | 9,480.77%7.47B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |